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Xiongwei Deng, Zhaoxia Yin, Jianqing Lu, Xianlei Li, Leihou Shao,Caiyan Zhao,Yishu Yang, Qin Hu, * Yan Wu, * and Wang Sheng * Figure S1 . High performance liquid chromatography (HPLC) analysis of purified S-Arg 4 peptides with reverse phase C18 column. Figure S2 . Liquid chromatography-mass spectrometry (LC-MS) analysis of S-Arg 4 peptides prepared by solid phase peptide synthesis. The major peak (MW=865.7) is consistent with the estimated product molecular weight of 865.06.
Scheme S1. Synthesis process of carboxymethyl dextran (CMD). Figure S19 . Body weights measurements. No significant differences in body weights were found in two tumor mouse models upon treatment with saline, GSH-CMINs, CMINs (2 mg/kg of miR-34a) and CMINs (4 mg/kg of miR-34a).
